Good stuff MisterS - seems to me you are right
on it. And yes plenty of adjuvant work going on now
in ddRNAi - best route to commercialization.
The chronic pain programme is actually one now
too - includes to better utilize morphine at lower doses.
Pfizer will love it when the good data comes in, esp as it has Chinese connection
- Forums
- ASX - By Stock
- combination treatments
Good stuff MisterS - seems to me you are righton it. And yes...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug